AEON Biopharma, Inc. Net Fee Amt
AEON Biopharma, Inc. (AEON) had Net Fee Amt of $625.34 as of 2026-07-14, per its S-1MEF filed 2026-07-13.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-13
- 2026-07-14: Net Fee Amt $625.34.
- 2026-07-09: Net Fee Amt $297.78.
- 2026-07-06: Net Fee Amt $5.96K.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-14 | $625.34 S-1MEF · filed 2026-07-13 |
| 2026-07-09 | $297.78 S-1/A · filed 2026-07-09 |
| 2026-07-06 | $5.96K S-1 · filed 2026-07-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |